Renflexis 100 MG vials
Ended Awarded
- Contract number
- SPE2DB25FXB78
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,228
Award facts
- Contract value 100% obligated
- $19,228.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Renflexis 100 mg vials, a pharmaceutical product used in military and federal healthcare settings. This firm fixed price delivery order, valued at $19,228.46, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The award was made without set-aside designation through open competition, and performance will be completed by August 29, 2025, with fulfillment conducted from the contractor's Conshohocken, Pennsylvania location.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant role in federal medical procurement through its comprehensive supply of brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The DLA Troop Support Medical IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply critical medical products to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. This delivery order exemplifies the company's consistent capability to fulfill federal medical supply requirements through competitive procurement mechanisms and firm fixed pricing arrangements ranging from minimal to substantial order values.
Quick answers
Who was awarded contract SPE2DB25FXB78?
SPE2DB25FXB78 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FXB78 worth?
The government has obligated $19,228 on SPE2DB25FXB78.
Is contract SPE2DB25FXB78 an order under another contract?
Yes. SPE2DB25FXB78 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FXB78 competed?
The extent of competition for SPE2DB25FXB78 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award